Literature DB >> 20584453

Intracranial Arterial Dissection Related to HIV Infection. A Case Report with Histology.

D Lefeuvre1, L Liebenberg, A Taylor.   

Abstract

SUMMARY: There are many reasons for patients infected with human immunodeficiency virus (HIV) to develop cerebrovascular disease. The HIV virus itself however may be a cause of vessel wall pathology. We present a clinical and pathological study of a patient who was HIV positive and presented with a subarachnoid haemorrhage. Cerebral angiography and later histology confirm that there was extensive vessel wall injury with dissection and a false aneurysm of the right middle cerebral artery.

Entities:  

Year:  2006        PMID: 20584453      PMCID: PMC3399757          DOI: 10.1177/159101990501100413

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  15 in total

1.  Viral load of the human immunodeficiency virus could be an independent risk factor for endothelial dysfunction.

Authors:  Arnon Blum; Vered Hadas; Michael Burke; Israel Yust; Ada Kessler
Journal:  Clin Cardiol       Date:  2005-03       Impact factor: 2.882

Review 2.  Vasculitides associated with HIV infection.

Authors:  R Chetty
Journal:  J Clin Pathol       Date:  2001-04       Impact factor: 3.411

Review 3.  Atherosclerotic cardiovascular disease risk in the HAART-treated HIV-1 population.

Authors:  Nehal Mehta; Muredach Reilly
Journal:  HIV Clin Trials       Date:  2005 Jan-Feb

Review 4.  Vasculitis associated with infectious agents.

Authors:  J T Lie
Journal:  Curr Opin Rheumatol       Date:  1996-01       Impact factor: 5.006

5.  Spontaneous subarachnoid hemorrhage in an HIV patient.

Authors:  M Silvestrini; R Floris; M Tagliati; P Stanzione; G Sancesario
Journal:  Ital J Neurol Sci       Date:  1990-10

6.  Cerebrovascular disease in HIV-infected pediatric patients: neuroimaging findings.

Authors:  Athos D Patsalides; Lauren V Wood; Gokce K Atac; Eileen Sandifer; John A Butman; Nicholas J Patronas
Journal:  AJR Am J Roentgenol       Date:  2002-10       Impact factor: 3.959

7.  Acquired immunodeficiency syndrome and the risk of stroke.

Authors:  John W Cole; Amelia N Pinto; J Richard Hebel; David W Buchholz; Christopher J Earley; Constance J Johnson; Richard F Macko; Thomas R Price; Michael A Sloan; Barney J Stern; Robert J Wityk; Marcella A Wozniak; Steven J Kittner
Journal:  Stroke       Date:  2003-12-18       Impact factor: 7.914

8.  Vasa vasorum of the intracranial arteries.

Authors:  M Takaba; S Endo; M Kurimoto; N Kuwayama; M Nishijima; A Takaku
Journal:  Acta Neurochir (Wien)       Date:  1998       Impact factor: 2.216

Review 9.  Thrombosis and a hypercoagulable state in HIV-infected patients.

Authors:  Yu-Min P Shen; Eugene P Frenkel
Journal:  Clin Appl Thromb Hemost       Date:  2004-07       Impact factor: 2.389

10.  Arteriopathy in children with acquired immune deficiency syndrome.

Authors:  V V Joshi; B Pawel; E Connor; L Sharer; J M Oleske; S Morrison; J Marin-Garcia
Journal:  Pediatr Pathol       Date:  1987
View more
  3 in total

1.  Aneurysmal vasculopathy in human-acquired immunodeficiency virus-infected adults: Imaging case series and review of the literature.

Authors:  Jayesh P Thawani; Nikhil R Nayak; Jared M Pisapia; Dmitriy Petrov; Bryan A Pukenas; Robert W Hurst; Michelle J Smith
Journal:  Interv Neuroradiol       Date:  2015-05-28       Impact factor: 1.610

2.  Successful endovascular treatment of three fusiform cerebral aneurysms with the Pipeline Embolization Device in a patient with dilating HIV vasculopathy.

Authors:  Josser E Delgado Almandoz; Benjamin M Crandall; Jennifer L Fease; Jill M Scholz; Ruth E Anderson; Yasha Kadkhodayan; David E Tubman
Journal:  BMJ Case Rep       Date:  2013-02-10

Review 3.  Stroke in Human Immunodeficiency Virus-infected Individuals in Sub-Saharan Africa (SSA): A Systematic Review.

Authors:  Amir Abdallah; Jonathan L Chang; Cumara B O'Carroll; Abdu Musubire; Felicia C Chow; Anthony L Wilson; Mark J Siedner
Journal:  J Stroke Cerebrovasc Dis       Date:  2018-04-05       Impact factor: 2.677

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.